FOMC minutes confirm they are looking at buying at longer end of curve. NAB’s Ray Attrill say that this will perhaps happen sooner than expected.

Trump is ready to give the keys to the White House. NAB’s Rodrigo Catril says the news has given the market some positivity, along with Janet Yellen set to become Treasury Secretary in the US, together with more vaccine hopes.

More vaccine news today, this time from Astra Zeneca. NAB’s David de Garis says we’re seeing the return of hotels and airlines stocks at the expense of the tech sector, whilst the US dollar has been helped by better than expected Markit PMIs.

Australia’s 2021 growth forecast has been revised. NAB’s Tapas Strickland talks through the good news, plus the spat between the US Fed and the Treasury.

The ferocity of the virus numbers of the US is seeing markets taking a more pessimistic short term view, despite positive vaccine news, says NAB’s Gavin Friend.

Pfizer is days away from submitted their vaccine for FDA approval. The markets haven’t been excited by the news. NAB’s David de Garis says rising COVID numbers have overshadowed the response.

Markets take a breather for now, but NAB’s Tapas Strickland says news from the Oxford vaccine trial are imminent and we could see a repeat of the reaction to the first two bits of trial news.

It’s all about the vaccine, says NAB’s Rodrigo Catril, as Moderna announces successful trials, with the markets ignoring the likely economic hit for Q3 and Q4.